Universal Health (UHS) Ratios
Universal Health Ratios
MX:UHS's free cash flow for Q3 2026 was $421.61M. For the 2026 fiscal year, MX:UHS's free cash flow was decreased by $-214.94M and operating cash flow was $636.56M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.05 | 1.27 | 1.40 | 1.33 | 1.14 |
| Quick Ratio | 0.98 | 1.17 | 1.29 | 1.21 | 1.04 |
| Cash Ratio | 0.04 | 0.06 | 0.06 | 0.05 | 0.06 |
| Solvency Ratio | 0.25 | 0.22 | 0.17 | 0.17 | 0.22 |
| Operating Cash Flow Ratio | 0.58 | 0.94 | 0.63 | 0.52 | 0.45 |
| Short-Term Operating Cash Flow Coverage | 2.27 | 51.60 | 10.01 | 12.23 | 18.25 |
| Net Current Asset Value | $ -5.14B | $ -4.89B | $ -4.95B | $ -4.99B | $ -4.63B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.35 | 0.34 | 0.38 | 0.39 | 0.35 |
| Debt-to-Equity Ratio | 0.76 | 0.74 | 0.87 | 0.89 | 0.75 |
| Debt-to-Capital Ratio | 0.43 | 0.43 | 0.47 | 0.47 | 0.43 |
| Long-Term Debt-to-Capital Ratio | 0.37 | 0.40 | 0.44 | 0.44 | 0.40 |
| Financial Leverage Ratio | 2.19 | 2.17 | 2.27 | 2.28 | 2.15 |
| Debt Service Coverage Ratio | 2.33 | 8.48 | 4.46 | 6.54 | 12.00 |
| Interest Coverage Ratio | 12.68 | 8.97 | 5.67 | 7.89 | 15.99 |
| Debt to Market Cap | 0.37 | 0.38 | 0.46 | 0.47 | 0.39 |
| Interest Debt Per Share | 89.09 | 77.28 | 80.41 | 73.83 | 56.29 |
| Net Debt to EBITDA | 1.96 | 2.13 | 3.07 | 3.28 | 2.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 90.45% | 89.97% | 89.27% | 89.00% | 88.71% |
| EBIT Margin | 12.23% | 10.62% | 8.00% | 7.41% | 10.89% |
| EBITDA Margin | 15.80% | 14.31% | 11.98% | 11.75% | 15.11% |
| Operating Profit Margin | 11.48% | 10.63% | 8.23% | 7.49% | 10.78% |
| Pretax Profit Margin | 11.36% | 9.46% | 6.58% | 6.46% | 10.23% |
| Net Profit Margin | 8.57% | 7.22% | 5.03% | 5.04% | 7.84% |
| Continuous Operations Profit Margin | 8.70% | 7.35% | 5.04% | 4.90% | 7.81% |
| Net Income Per EBT | 75.49% | 76.24% | 76.33% | 77.99% | 76.67% |
| EBT Per EBIT | 98.90% | 89.07% | 80.01% | 86.32% | 94.88% |
| Return on Assets (ROA) | 9.33% | 7.89% | 5.14% | 5.01% | 7.57% |
| Return on Equity (ROE) | 20.46% | 17.13% | 11.67% | 11.41% | 16.28% |
| Return on Capital Employed (ROCE) | 15.68% | 13.72% | 9.83% | 8.67% | 12.27% |
| Return on Invested Capital (ROIC) | 11.29% | 10.55% | 7.40% | 6.49% | 9.28% |
| Return on Tangible Assets | 12.52% | 10.92% | 7.15% | 7.05% | 10.86% |
| Earnings Yield | 10.74% | 9.56% | 6.79% | 6.56% | 9.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.67 | 7.27 | 6.38 | 6.64 | 7.24 |
| Payables Turnover | 2.21 | 2.51 | 2.50 | 2.32 | 2.17 |
| Inventory Turnover | 7.15 | 7.19 | 7.06 | 6.75 | 6.90 |
| Fixed Asset Turnover | 2.35 | 2.26 | 2.18 | 2.10 | 2.03 |
| Asset Turnover | 1.09 | 1.09 | 1.02 | 0.99 | 0.97 |
| Working Capital Turnover Ratio | 44.86 | 22.55 | 20.10 | 29.70 | 23.41 |
| Cash Conversion Cycle | -59.27 | -44.27 | -37.33 | -48.54 | -65.19 |
| Days of Sales Outstanding | 54.70 | 50.22 | 57.20 | 54.96 | 50.43 |
| Days of Inventory Outstanding | 51.07 | 50.79 | 51.67 | 54.10 | 52.90 |
| Days of Payables Outstanding | 165.04 | 145.28 | 146.20 | 157.60 | 168.52 |
| Operating Cycle | 105.77 | 101.01 | 108.87 | 109.06 | 103.33 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 29.32 | 31.06 | 18.29 | 13.62 | 10.71 |
| Free Cash Flow Per Share | 13.36 | 16.88 | 7.57 | 3.58 | 0.34 |
| Dividend Paid and CapEx Coverage Ratio | 1.75 | 2.07 | 1.59 | 1.26 | 0.96 |
| Capital Expenditure Coverage Ratio | 1.84 | 2.19 | 1.71 | 1.36 | 1.03 |
| Operating Cash Flow Coverage Ratio | 0.34 | 0.42 | 0.24 | 0.19 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.13 | 0.09 | 0.07 | 0.07 |
| Free Cash Flow Yield | 6.13% | 9.41% | 4.97% | 2.54% | 0.26% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.31 | 10.46 | 14.72 | 15.25 | 10.79 |
| Price-to-Sales (P/S) Ratio | 0.80 | 0.75 | 0.74 | 0.77 | 0.85 |
| Price-to-Book (P/B) Ratio | 1.91 | 1.79 | 1.72 | 1.74 | 1.76 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.32 | 10.63 | 20.14 | 39.32 | 381.63 |
| Price-to-Operating Cash Flow Ratio | 7.44 | 5.78 | 8.34 | 10.34 | 12.11 |
| Price-to-Earnings Growth (PEG) Ratio | 0.26 | 0.16 | 1.21 | -0.66 | 1.28 |
| Enterprise Value Multiple | 7.01 | 7.40 | 9.24 | 9.82 | 7.93 |
| Enterprise Value | 19.23B | 16.77B | 15.81B | 15.47B | 15.14B |
| EV to EBITDA | 7.01 | 7.40 | 9.24 | 9.82 | 7.93 |
| EV to Sales | 1.11 | 1.06 | 1.11 | 1.15 | 1.20 |
| EV to Free Cash Flow | 22.65 | 14.93 | 30.14 | 59.04 | 540.15 |
| EV to Operating Cash Flow | 10.32 | 8.11 | 12.47 | 15.53 | 17.14 |
| Tangible Book Value Per Share | 52.58 | 41.37 | 32.74 | 28.18 | 27.09 |
| Shareholders’ Equity Per Share | 114.43 | 100.16 | 88.70 | 80.97 | 73.80 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.22 | 0.24 | 0.24 | 0.24 |
| Revenue Per Share | 273.11 | 237.82 | 206.03 | 183.26 | 153.20 |
| Net Income Per Share | 23.42 | 17.16 | 10.35 | 9.24 | 12.02 |
| Tax Burden | 0.75 | 0.76 | 0.76 | 0.78 | 0.77 |
| Interest Burden | 0.93 | 0.89 | 0.82 | 0.87 | 0.94 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.47 | 0.48 | 0.51 | 0.51 | 0.50 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.23 | 1.78 | 1.77 | 1.52 | 0.89 |
Currency in USD